Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy

与黑色素瘤免疫疗法协同作用的聚焦超声治疗方案

基本信息

  • 批准号:
    10186745
  • 负责人:
  • 金额:
    $ 64.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Immunotherapies (ITx) for melanoma have led to marked improvements in clinical outcomes. However, objective response rates remain quite low (10-30%) because T-cells fail to infiltrate metastases in many patients. Thus, the translation of adjunct approaches that enhance T-cell infiltration and/or lift the immunosuppressive tumor microenvironment could vastly expand the population of melanoma patients exhibiting durable responses to immunotherapy. Toward this goal, we hypothesize that perturbation of the melanoma microenvironment with focused ultrasound (FUS), applied in energy regimens designed to elicit thermal ablation (T-FUS) and/or microbubble cavitation (M-FUS), can stimulate immunologic responses that are both intrinsically therapeutic and synergistic with translatable immunotherapies. Indeed, our pilot studies indicate that, even when applied to only a small fraction of tumor volume, both T-FUS and M-FUS cooperate with the immune system to control melanoma. This proposal is comprised of 3 specific aims that will serve to define differences in the innate and adaptive immune responses that are elicited by applying different FUS energy regimes to tumors, identify barriers to tumor immunity, and ascertain treatment protocols that more effectively combine FUS energy regimes with adjunct immunotherapies for treating metastatic melanoma. Specific Aim 1 will first characterize thermal and mechanical energy deposition generated during the application of T-FUS and M-FUS to B16F10 melanoma. Then, using bilateral melanoma tumor models, we will identify T-FUS and M-FUS “ablation fractions” that, when combined with first line αPD1 immunotherapy for melanoma, yield most efficacious immunological control of a distant tumor. These ablation fractions will be carried forward through the rest of the proposal. Specific Aim 2 will entail determining the impact of the selected FUS energy regimes with αPD1 on discrete factors that influence the sequential steps involved in the activation, expansion, and recruitment of T cells to the microenvironments of FUS-treated and distant tumors. In turn, this will help us define optimized protocols for immune cell activation and understand aspects of FUS modalities that are beneficial or detrimental to T cell-mediated tumor control. Additional studies under Aim 2 will assess the mechanisms of adaptive resistance elicited by application of FUS in these selected energy regimes. This will allow us to understand the diversity and intensity of compensatory anti-inflammatory responses to FUS, which will be a critical aspect in optimizing the combination of FUS with anti-tumor immunotherapy. Finally, Specific Aim 3 will both ascertain the ability of FUS to promote antibody entrance to tumor and utilize information from previous aims to identify and test combinations of selected FUS energy regimens and immunotherapeutic drugs in treatments that we hypothesize will yield most effective control of disseminated tumors. We believe the highly systematic and directed approach proposed here is more likely to lead to successful clinical therapies for melanoma patients with limited T cell infiltration.
黑色素瘤的免疫疗法(ITx)已导致临床结局的显著改善。然而,在这方面, 由于许多患者的T细胞未能浸润转移灶,客观缓解率仍然相当低(10-30%)。 因此,增强T细胞浸润和/或提高免疫抑制性的辅助方法的翻译是可能的。 肿瘤微环境可以极大地扩大黑色素瘤患者的群体, 免疫疗法为了实现这一目标,我们假设黑色素瘤微环境的扰动, 聚焦超声(FUS),应用于旨在引起热消融(T-FUS)的能量方案,和/或 微泡空化(M-FUS)可以刺激免疫应答,其本质上是治疗性的, 与可翻译的免疫疗法协同。事实上,我们的试点研究表明,即使只应用于 肿瘤体积的一小部分,T-FUS和M-FUS都与免疫系统合作, 黑素瘤 该提案由三个具体目标组成,这些目标将有助于确定先天和 通过对肿瘤应用不同的FUS能量方案引起的适应性免疫应答, 肿瘤免疫,并确定治疗方案,更有效地结合联合收割机FUS能量制度, 用于治疗转移性黑素瘤的辅助免疫疗法。具体目标1将首先描述热特性, 在T-FUS和M-FUS应用于B16 F10黑色素瘤期间产生的机械能沉积。 然后,使用双侧黑色素瘤肿瘤模型,我们将确定T-FUS和M-FUS“消融分数”, 结合一线α PD 1免疫疗法治疗黑色素瘤,可产生最有效的免疫控制, 远处肿瘤这些消融分数将在提案的其余部分继续进行。具体目标2 将需要确定所选FUS能量状态与α PD 1对影响离散因素的影响 涉及T细胞活化、扩增和募集到微环境中的顺序步骤 FUS治疗的肿瘤和远处肿瘤。反过来,这将帮助我们定义免疫细胞激活的优化方案 并了解FUS模式对T细胞介导的肿瘤控制有益或有害的方面。 目标2下的其他研究将评估应用FUS引发适应性抗性的机制 在这些选定的能源制度。这将使我们能够了解代偿性的多样性和强度, FUS的抗炎反应,这将是优化FUS与 抗肿瘤免疫治疗。最后,特异性目标3将确定FUS促进抗体的能力 进入肿瘤,并利用来自先前目标的信息来识别和测试所选FUS的组合 能量疗法和免疫抑制药物的治疗,我们假设将产生最有效的控制 扩散性肿瘤我们认为,这里提出的高度系统化和有针对性的方法更有可能 从而为具有有限T细胞浸润的黑色素瘤患者带来成功的临床治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TIMOTHY N BULLOCK其他文献

TIMOTHY N BULLOCK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TIMOTHY N BULLOCK', 18)}}的其他基金

Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
与黑色素瘤免疫疗法协同作用的聚焦超声治疗方案
  • 批准号:
    10032967
  • 财政年份:
    2020
  • 资助金额:
    $ 64.9万
  • 项目类别:
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
与黑色素瘤免疫疗法协同作用的聚焦超声治疗方案
  • 批准号:
    10377443
  • 财政年份:
    2020
  • 资助金额:
    $ 64.9万
  • 项目类别:
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
与黑色素瘤免疫疗法协同作用的聚焦超声治疗方案
  • 批准号:
    10615036
  • 财政年份:
    2020
  • 资助金额:
    $ 64.9万
  • 项目类别:
Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBM
利用 MR 引导聚焦超声增强 GBM 免疫治疗
  • 批准号:
    10020956
  • 财政年份:
    2019
  • 资助金额:
    $ 64.9万
  • 项目类别:
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
通过 MR 引导聚焦超声将免疫治疗纳米颗粒递送至黑色素瘤
  • 批准号:
    8945980
  • 财政年份:
    2015
  • 资助金额:
    $ 64.9万
  • 项目类别:
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
通过 MR 引导聚焦超声将免疫治疗纳米颗粒递送至黑色素瘤
  • 批准号:
    9267820
  • 财政年份:
    2015
  • 资助金额:
    $ 64.9万
  • 项目类别:
BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 介导的 CD8 TIL 调节
  • 批准号:
    8844054
  • 财政年份:
    2014
  • 资助金额:
    $ 64.9万
  • 项目类别:
BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 介导的 CD8 TIL 调节
  • 批准号:
    8595301
  • 财政年份:
    2013
  • 资助金额:
    $ 64.9万
  • 项目类别:
BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 介导的 CD8 TIL 调节
  • 批准号:
    8439016
  • 财政年份:
    2013
  • 资助金额:
    $ 64.9万
  • 项目类别:
BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 介导的 CD8 TIL 调节
  • 批准号:
    8777888
  • 财政年份:
    2013
  • 资助金额:
    $ 64.9万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 64.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了